Di Nuzzo Private Wealth, Inc. Biomarin Pharmaceutical Inc Transaction History
Di Nuzzo Private Wealth, Inc.
- $618 Million
- Q4 2024
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 13 shares of BMRN stock, worth $856. This represents 0.0% of its overall portfolio holdings.
Number of Shares
13
Previous 24
45.83%
Holding current value
$856
Previous $1,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding BMRN
# of Institutions
648Shares Held
180MCall Options Held
2.03MPut Options Held
1.29M-
Black Rock Inc. New York, NY22.7MShares$1.5 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19.4MShares$1.28 Billion0.02% of portfolio
-
Primecap Management CO Pasadena, CA18.2MShares$1.2 Billion0.94% of portfolio
-
Dodge & Cox San Francisco, CA14.7MShares$971 Million0.61% of portfolio
-
Capital Research Global Investors Los Angeles, CA13MShares$856 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $12.2B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...